Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

152.90
Delayed Data
As of Aug 23
 -2.09 / -1.35%
Today’s Change
95.14
Today|||52-Week Range
157.41
+35.69%
Year-to-Date

Today’s Trading

Previous close154.99
Today’s open154.76
Day’s range152.75 - 154.93
Volume215,339
Average volume (3 months)308,711
Market cap$6.8B
Dividend yield--
Data as of 4:00pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+84.81%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)+35.13%
P/E ratio89.9
Price/Sales12.56
Price/Book14.97

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.72-0.95%
WSTWest Pharmaceutical ...-1.33-1.55%
MASIMasimo Corp-2.16-2.49%
TFXTeleflex Inc-5.37-2.52%
Data as of 4:03pm ET, 08/23/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts